These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

469 related articles for article (PubMed ID: 18202796)

  • 1. Prognostic implication of SYT-SSX fusion type in synovial sarcoma: a multi-institutional retrospective analysis in Japan.
    Takenaka S; Ueda T; Naka N; Araki N; Hashimoto N; Myoui A; Ozaki T; Nakayama T; Toguchida J; Tanaka K; Iwamoto Y; Matsumine A; Uchida A; Ieguchi M; Kaya M; Wada T; Baba I; Kudawara I; Aoki Y; Yoshikawa H
    Oncol Rep; 2008 Feb; 19(2):467-76. PubMed ID: 18202796
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of SYT-SSX fusion type on the clinical behavior of synovial sarcoma: a multi-institutional retrospective study of 243 patients.
    Ladanyi M; Antonescu CR; Leung DH; Woodruff JM; Kawai A; Healey JH; Brennan MF; Bridge JA; Neff JR; Barr FG; Goldsmith JD; Brooks JS; Goldblum JR; Ali SZ; Shipley J; Cooper CS; Fisher C; Skytting B; Larsson O
    Cancer Res; 2002 Jan; 62(1):135-40. PubMed ID: 11782370
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Histologic grade, but not SYT-SSX fusion type, is an important prognostic factor in patients with synovial sarcoma: a multicenter, retrospective analysis.
    Guillou L; Benhattar J; Bonichon F; Gallagher G; Terrier P; Stauffer E; Somerhausen Nde S; Michels JJ; Jundt G; Vince DR; Taylor S; Genevay M; Collin F; Trassard M; Coindre JM
    J Clin Oncol; 2004 Oct; 22(20):4040-50. PubMed ID: 15364967
    [TBL] [Abstract][Full Text] [Related]  

  • 4. SYT-SSX gene fusion as a determinant of morphology and prognosis in synovial sarcoma.
    Kawai A; Woodruff J; Healey JH; Brennan MF; Antonescu CR; Ladanyi M
    N Engl J Med; 1998 Jan; 338(3):153-60. PubMed ID: 9428816
    [TBL] [Abstract][Full Text] [Related]  

  • 5. SYT-SSX fusion genes and prognosis in synovial sarcoma.
    Mezzelani A; Mariani L; Tamborini E; Agus V; Riva C; Lo Vullo S; Fabbri A; Stumbo M; Azzarelli A; Casali PG; Gronchi A; Sozzi G; Pierotti MA; Pilotti S
    Br J Cancer; 2001 Nov; 85(10):1535-9. PubMed ID: 11720441
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The SYT-SSX1 variant of synovial sarcoma is associated with a high rate of tumor cell proliferation and poor clinical outcome.
    Nilsson G; Skytting B; Xie Y; Brodin B; Perfekt R; Mandahl N; Lundeberg J; Uhlén M; Larsson O
    Cancer Res; 1999 Jul; 59(13):3180-4. PubMed ID: 10397263
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Detection of SYT-SSX fusion transcripts in paraffin-embedded tissues of synovial sarcoma by reverse transcription-polymerase chain reaction.
    Wei Y; Wang J; Zhu X; Shi D; Hisaoka M; Hashimoto H
    Chin Med J (Engl); 2002 Jul; 115(7):1043-7. PubMed ID: 12150740
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular diagnosis of synovial sarcoma: RT-PCR detection of SYT-SSX1/2 fusion transcripts in paraffin-embedded tissue.
    Tvrdík D; Povýsil C; Svatosová J; Dundr P
    Med Sci Monit; 2005 Mar; 11(3):MT1-7. PubMed ID: 15735574
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dysadherin expression as a significant prognostic factor and as a determinant of histologic features in synovial sarcoma: special reference to its inverse relationship with E-cadherin expression.
    Izumi T; Oda Y; Hasegawa T; Nakanishi Y; Kawai A; Sonobe H; Takahira T; Kobayashi C; Yamamoto H; Tamiya S; Hirohashi S; Iwamoto Y; Tsuneyoshi M
    Am J Surg Pathol; 2007 Jan; 31(1):85-94. PubMed ID: 17197923
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical impact of molecular and cytogenetic findings in synovial sarcoma.
    Panagopoulos I; Mertens F; Isaksson M; Limon J; Gustafson P; Skytting B; Akerman M; Sciot R; Dal Cin P; Samson I; Iliszko M; Ryoe J; Dêbiec-Rychter M; Szadowska A; Brosjö O; Larsson O; Rydholm A; Mandahl N
    Genes Chromosomes Cancer; 2001 Aug; 31(4):362-72. PubMed ID: 11433527
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of SYT-SSX fusion types with proliferative activity and prognosis in synovial sarcoma.
    Inagaki H; Nagasaka T; Otsuka T; Sugiura E; Nakashima N; Eimoto T
    Mod Pathol; 2000 May; 13(5):482-8. PubMed ID: 10824918
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The classic prognostic factors tumor stage, tumor size, and tumor grade are the strongest predictors of outcome in synovial sarcoma: no role for SSX fusion type or ezrin expression.
    ten Heuvel SE; Hoekstra HJ; Bastiaannet E; Suurmeijer AJ
    Appl Immunohistochem Mol Morphol; 2009 May; 17(3):189-95. PubMed ID: 18997619
    [TBL] [Abstract][Full Text] [Related]  

  • 13. SYT-SSX fusion genes in synovial sarcoma of the thorax.
    Yano M; Toyooka S; Tsukuda K; Dote H; Morimoto Y; Ohata N; Ichimura K; Aoe M; Date H; Shimizu N
    Lung Cancer; 2004 Jun; 44(3):391-7. PubMed ID: 15140553
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Detection of the SYT-SSX fusion transcripts in formaldehyde-fixed, paraffin-embedded tissue: a reverse transcription polymerase chain reaction amplification assay useful in the diagnosis of synovial sarcoma.
    Lasota J; Jasinski M; Debiec-Rychter M; Szadowska A; Limon J; Miettinen M
    Mod Pathol; 1998 Jul; 11(7):626-33. PubMed ID: 9688183
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular diagnosis of synovial sarcoma and characterization of a variant SYT-SSX2 fusion transcript.
    Fligman I; Lonardo F; Jhanwar SC; Gerald WL; Woodruff J; Ladanyi M
    Am J Pathol; 1995 Dec; 147(6):1592-9. PubMed ID: 7495284
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of receptor tyrosine kinases epidermal growth factor receptor and HER-2/neu in synovial sarcoma.
    Thomas DG; Giordano TJ; Sanders D; Biermann S; Sondak VK; Trent JC; Yu D; Pollock RE; Baker L
    Cancer; 2005 Feb; 103(4):830-8. PubMed ID: 15641030
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic implication of SYT-SSX fusion type and clinicopathological parameters for tumor-related death, recurrence, and metastasis in synovial sarcoma.
    Sun Y; Sun B; Wang J; Cai W; Zhao X; Zhang S; Hao X
    Cancer Sci; 2009 Jun; 100(6):1018-25. PubMed ID: 19385976
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Detection of SYT-SSX fusion transcripts in synovial sarcoma by reverse transcription-polymerase chain reaction using archival paraffin-embedded tissues.
    Tsuji S; Hisaoka M; Morimitsu Y; Hashimoto H; Shimajiri S; Komiya S; Ushijima M; Nakamura T
    Am J Pathol; 1998 Dec; 153(6):1807-12. PubMed ID: 9846971
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Detection of SYT-SSX fusion gene in paraffin-embedded tissues and its clinicopathologic significance for synovial sarcoma].
    Wei Y; Sun M; Zhu H; Xu Z; Wang J; Zhu X
    Zhonghua Bing Li Xue Za Zhi; 2001 Dec; 30(6):426-30. PubMed ID: 11866984
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Should molecular testing be required for diagnosing synovial sarcoma? A prospective study of 204 cases.
    Coindre JM; Pelmus M; Hostein I; Lussan C; Bui BN; Guillou L
    Cancer; 2003 Dec; 98(12):2700-7. PubMed ID: 14669292
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.